Weiss Multi Strategy Advisers LLC Neurocrine Biosciences Inc Transaction History

Weiss Multi Strategy Advisers LLC

$0
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$106.07 - $132.76 $1.22 Million - $1.52 Million	11,480 New	11,480 $1.51 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $535,835 - $707,494	7,070 Added 35.35%	27,070 $2.64 Million
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $1.02 Million - $1.34 Million	-14,105 Reduced 41.36%	20,000 $1.88 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $92,473 - $123,321	1,161 Added 3.52%	34,105 $2.91 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $62,049 - $71,301	720 Added 2.23%	32,944 $3.16 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $103,023 - $117,815	1,152 Added 3.71%	32,224 $3.14 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $364,203 - $496,584	-4,159 Reduced 11.8%	31,072 $3.02 Million
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $436,983 - $544,683	-5,028 Reduced 12.49%	35,231 $3.38 Million
Q3 2020 Nov 16, 2020	SELL	$96.16 - $135.15 $215,494 - $302,871	-2,241 Reduced 5.27%	40,259 $3.87 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $712,969 - $1.09 Million	-8,379 Reduced 16.47%	42,500 $5.19 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $159,308 - $241,284	-2,121 Reduced 4.0%	50,879 $4.4 Million
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $260,400 - $355,710	3,000 Added 6.0%	53,000 $5.7 Million
Q3 2019 Nov 14, 2019	SELL	$83.82 - $101.5 $1.26 Million - $1.52 Million	-15,000 Reduced 23.08%	50,000 $4.51 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $69,310 - $91,530	-1,000 Reduced 1.52%	65,000 $5.73 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $1.3 Million - $2.36 Million	-19,000 Reduced 22.35%	66,000 $4.71 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $229,302 - $291,846	-2,319 Reduced 2.66%	85,000 $10.5 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $927,620 - $1.31 Million	12,319 Added 16.43%	87,319 $8.58 Million
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $2.5 Million - $3.05 Million	33,000 Added 78.57%	75,000 $6.22 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $409,710 - $543,130	7,000 Added 20.0%	42,000 $3.26 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $1.68 Million - $2.14 Million	35,000	35,000 $2.15 Million

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.52 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$782 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$391 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$283 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Account